Related Experiment Video
Updated: May 1, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
Glycemic control mentored implementation: creating a national network of shared information
Joint Commission Journal on Quality and Patient Safety
|April 16, 2014
Summary
The Society of Hospital Medicine
Area of Science:
- Quality Improvement
- Healthcare Management
- Endocrinology
Background:
- The Society of Hospital Medicine (SHM) developed the Glycemic Control Mentored Implementation (GCMI) program to enhance inpatient glycemic control.
- This program is designed for both diabetic and nondiabetic patients within hospital settings.
- It functions as an improvement collaborative, focusing on educating and mentoring hospital quality teams.
Purpose of the Study:
- To assess the effectiveness of the GCMI program in improving inpatient glycemic control.
- To evaluate the utility of mentorship and collaborative learning in quality improvement initiatives.
- To determine participant satisfaction and perceived benefits of the GCMI program.
Main Methods:
- Hospital quality improvement (QI) teams applied for GCMI participation between 2009 and 2012.
- Accepted sites received mentorship from either a hospitalist or endocrinologist.
- Utilized SHM's Implementation Guide, online resources, data tracking tools, webinars, and an interactive list-serve.
Main Results:
- 114 hospital QI teams enrolled, with 90 completing the program.
- Positive feedback highlighted the listserve, Data Center, and mentorship as most effective.
- 95% of respondents would recommend the program; participants reported improved leadership and institutional support.
Conclusions:
- The GCMI program effectively supported hospital quality teams in improving glycemic control.
- Key benefits included overcoming barriers, peer networking, data analysis, and leadership development.
- The program's structure is adaptable for other multisite quality improvement goals.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Nursing Clinical Information System
1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
